Literature DB >> 19541709

Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia.

A Singanayagam1, J D Chalmers, A T Hill.   

Abstract

The aim of our study was to investigate if hypoglycaemia correlates with outcome in community-acquired pneumonia (CAP). We performed a prospective, observational study of consecutive patients presenting with a primary diagnosis of CAP in Lothian (UK). Admission plasma glucose was measured and, on this basis, patients were divided into two groups, hypoglycaemic (<4.4 mmol x L(-1) or <79.0 mg x dL(-1)) and nonhypoglycaemic (> or = 4.4 mmol x L(-1) or > or = 79.0 mg x dL(-1)). Outcomes of interest were 30-day mortality, need for mechanical ventilation and inotropic support. Multivariable logistic regression was used to compare these outcomes in hypoglycaemic patients to nonhypoglycaemic patients, adjusting for diabetes mellitus, prior statin use and Pneumonia Severity Index. In total, 1,050 patients were included in the study with 5.4% classified as hypoglycaemic. Increased rates of 30-day mortality (28.1% versus 7.5%, p<0.0001), need for mechanical ventilation (29.8% versus 6.5%, p<0.0001) and need for inotropic support (21.1% versus 4.8%, p<0.0001) were observed in hypoglycaemic patients compared with nonhypoglycaemic patients. On multivariable analysis, hypoglycaemia was independently associated with increased 30-day mortality (OR 2.25, 95% CI 1.1-4.7; p = 0.03), need for mechanical ventilation (OR 3.8, 95% CI 1.9-7.5; p = 0.0002) and need for inotropic support (OR, 2.9, 95% CI 1.4-6.3; p = 0.0006). Admission hypoglycaemia is associated with increased 30-day mortality, need for mechanical ventilation and inotropic support in patients presenting with CAP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541709     DOI: 10.1183/09031936.00197008

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Discordance of physician clinical judgment vs. pneumonia severity index (PSI) score to admit patients with low risk community-acquired pneumonia: a prospective multicenter study.

Authors:  Pedro J Marcos; Marcos I Restrepo; Francisco J González-Barcala; Nilam J Soni; Iria Vidal; Pilar Sanjuàn; Diego Llinares; Lucía Ferreira-Gonzalez; Carlos Rábade; Isabel Otero-González; Pedro Marcos; Héctor Verea-Hernando
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

2.  Hypoglycemia revisited in the acute care setting.

Authors:  Shih-Hung Tsai; Yen-Yue Lin; Chin-Wang Hsu; Chien-Sheng Cheng; Der-Ming Chu
Journal:  Yonsei Med J       Date:  2011-11       Impact factor: 2.759

3.  Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study.

Authors:  Philipp M Lepper; Sebastian Ott; Eveline Nüesch; Maximilian von Eynatten; Christian Schumann; Mathias W Pletz; Nicole M Mealing; Tobias Welte; Torsten T Bauer; Norbert Suttorp; Peter Jüni; Robert Bals; Gernot Rohde
Journal:  BMJ       Date:  2012-05-28

Review 4.  Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?

Authors:  Lise Van Wyngene; Jolien Vandewalle; Claude Libert
Journal:  EMBO Mol Med       Date:  2018-08       Impact factor: 12.137

5.  Sepsis patients with complication of hypoglycemia and hypoalbuminemia are an early and easy identification of high mortality risk.

Authors:  Makoto Furukawa; Kosaku Kinoshita; Junko Yamaguchi; Satoshi Hori; Atsushi Sakurai
Journal:  Intern Emerg Med       Date:  2019-02-07       Impact factor: 3.397

Review 6.  Metabolic Alterations in Sepsis.

Authors:  Weronika Wasyluk; Agnieszka Zwolak
Journal:  J Clin Med       Date:  2021-05-29       Impact factor: 4.241

7.  Sepsis-associated hypoglycemia on admission is associated with increased mortality in intensive care unit patients.

Authors:  Yumi Mitsuyama; Kentaro Shimizu; Sho Komukai; Atsushi Hirayama; Ryosuke Takegawa; Takeshi Ebihara; Tetsuhisa Kitamura; Hiroshi Ogura; Takeshi Shimazu
Journal:  Acute Med Surg       Date:  2022-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.